Cost-effectiveness analysis of the use of mepolizumab in omalizumab-resistant patients with severe asthma

Objective. To determine the clinical and economic consequences of the drug mepolizumab in patients with severe bronchial asthma (SBA) and the ineff ectiveness of omalizumab. Methods. We conducted cost-eff ectiveness and budget impact analysis of the use of mepolizumab or omalizumab in omalizumab-ref...

Full description

Saved in:
Bibliographic Details
Main Authors: A. G. Tolkushin (Author), V. A. Rogov (Author), D. A. Ivanov (Author), N. L. Pogudina (Author)
Format: Book
Published: Izdatelstvo OKI, 2019-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available